Skip to main content
TipRanks
Go Ultimate75% OFF

Brii Biosciences Limited (2137) Drug Pipeline

3 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Brii-835 (Vir-2218), Brii-179, Peg-IfnαChronic Hepatitis B Virus (Hbv) InfectionPhase IIRecruitingA Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)Oct 12, 2024―
Brii-835 (Vir-2218), Brii-179, Peg-IfnαFor Treatment Of Chronic Hepatitis B Virus InfectionPhase IIActive Not RecruitingStudy to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)Jun 28, 2024―
Brii-296, Depo MedrolSevere Postpartum DepressionPhase IICompletedA Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)Sep 21, 2023―
Peg-Ifnα, Brii-835Chronic Hepatitis B Virus InfectionPhase IIActive Not RecruitingInvestigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV PatientsJul 21, 2023―
Brii-297Postpartum DepressionPhase ICompletedA Study of BRII-297 in Healthy Adult SubjectsApr 12, 2023―
Brii-196 And Brii-198Covid-19Phase IICompletedA Study of Human Monoclonal Antibodies, BRII-196 and BRII-198Mar 04, 2021―
Brii-835 (Vir-2218), Brii-179 (Vbi-2601) With Ifn-Α, Brii-179 (Vbi-2601)Hepatitis B, ChronicPhase IICompletedStudy to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) InfectionFeb 07, 2021―
Brii-196 And Brii-198Covid-19Phase ICompletedA Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198Dec 17, 2020―
Vir-2218Hepatitis B, ChronicPhase IICompletedStudy of VIR-2218 in Patients With Chronic Hepatitis B in Mainland ChinaAug 07, 2020―
Brii-196Covid-19Phase ICompletedSafety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196Jul 14, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Brii Biosciences Limited (HK:2137) have in its pipeline
Brii Biosciences Limited HK:2137 is currently developing the following drugs: Brii-835 (Vir-2218), Brii-179, Peg-Ifnα, Brii-296, Depo Medrol, Peg-Ifnα, Brii-835, Brii-297, Brii-196 And Brii-198, Brii-835 (Vir-2218), Brii-179 (Vbi-2601) With Ifn-Α, Brii-179 (Vbi-2601), Vir-2218, Brii-196, Brii-198. These drug candidates are in various stages of clinical development as the company works toward FDA approval.